[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastroesophageal-reflux-gerd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastroesophageal-reflux-gerd":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":5},"100648967","transit-bipartition-after-sleeve-gastrectomy-100648967",false,"NCT07728682","Transit Bipartition After Sleeve Gastrectomy","Clinical, Metabolic, and Physiological Evaluation of Conversion From Sleeve Gastrectomy to Intestinal Transit Bipartition","BTT-SLEEVE","Inclusion Criteria:\n\n* Age 18 years or older;\n* Previous sleeve gastrectomy for the treatment of obesity;\n* Follow-up at the HCRP gastrosurgery\u002Fbariatric surgery outpatient clinic through 2026;\n* Clinical evaluation supporting revisional conversion to intestinal transit bipartition;\n* Willingness to undergo the new surgical procedure and provide written informed consent.\n\nExclusion Criteria:\n\n* Liver cirrhosis;\n* Absence of willingness to undergo a new surgical procedure.","ALL","18 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This prospective, single-center study will evaluate adults undergoing revisional conversion from sleeve gastrectomy to intestinal transit bipartition. Forty participants will complete clinical, endoscopic, physiological, metabolic, hormonal, imaging, and stool assessments before surgery and during follow-up. The primary outcome is the within-participant change in solid-meal gastric emptying half-time (T½), measured by standardized scintigraphy from baseline to 6 months. Secondary and exploratory outcomes include reflux symptoms, DeMeester score and acid exposure, route-specific gastric transit, GLP-1 and ghrelin responses, glucose metabolism, fecal elastase, gut microbiota, body-weight trajectory, comorbidities, gastroileal anastomotic caliber, and safety.",[27,28,29,30],"Obesity & Overweight","Gastroesophageal Reflux (GERD)","Weight Recurrence","Bariatric Surgery",[32,33,34,35,36,37,38,39,40],"sleeve gastrectomy","transit bipartition","gastric emptying","scintyigraphy","T1\u002F2","DeMeester score","gastroileal anastomosis","GLP-1","fecal elastase","NOT_YET_RECRUITING","2026-07-30",{"date":44,"type":45},"2026-08-03","ACTUAL",{"date":47,"type":21},"2026-08-02",{"date":49,"type":21},"2027-09-30",{"name":51,"class":52},"Hospital das Clínicas de Ribeirão Preto","OTHER"]